# Neuralink Implants First Canadian ALS Patient with BCI Device

> clinical trial · REPORTED · 2026-07-02

On July 2, 2026, Neuralink implanted its brain-computer interface device in its first Canadian patient with ALS, expanding the company's PRIME study internationally beyond the United States and the UAE. The implant is designed to allow the paralyzed patient to control digital devices using thought alone.

About Neuralink: Neuralink is a neurotechnology company co-founded by Elon Musk that develops fully implantable brain-computer interfaces, with its lead Telepathy device enabling people with severe paralysis to control computers, phones, and robotic arms using neural signals.

- Company: Neuralink
- Sector: neurotech
- Primary source: https://www.mobihealthnews.com/news/elon-musks-neuralink-device-blindsight-gets-fda-breakthrough-device-designation

---
Source: MedFuel Intel news monitor. Verification tier: REPORTED. Informational only, not investment advice. Corrections: media@medfuelinc.com.